Skip to content

The effect of vitamin B1 on the complications after the insertion of Intra uterin device

The effect of vitamin B1 on the complications after the insertion of Intra uterin device in women gravid of 1-4

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012073010451N1
Enrollment
110
Registered
2012-12-21
Start date
2012-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persons encountering health services in circumstances related to reproduction. Insertion of (intrauterine) contraceptive device

Interventions

Sponsors

Islamic Azad University,Borujerd Branch
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: : age18-35; Gravid1-4; being literate; using IUD for the first time; having regular menstruation period between 26-30 days; menstruations bleeding duration between 3-7 days;the number of used sanitary napkins between 10-14 numbers.Exclusion criteria:Existing of any kind of genital system diseases ;Background for kidney stone or any problems; any kind of diagnosed physical and psychological diseases; severe dysmenorea, according to visual analogue scale.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain resultant from insertion IUD. Timepoint: Within 5 months with intervals of 1 month before intervention, and within 3 months after intervention and 1 month after finishing the intervention. Method of measurement: visual analogue scale.;Bleeding. Timepoint: Within 5 months with intervals of 1 month before intervention, and within 3 months after intervention and 1 month after finishing the intervention. Method of measurement: Higham chart.

Secondary

MeasureTime frame
Spotting. Timepoint: Within 5 months with intervals of 1 month before intervention, and within 3 months after intervention and 1 month after finishing the intervention. Method of measurement: Higham chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSayyahi Masoume

Ministry of Health and Treatment

SAYYAHI724@GMAIL.COM+66 2 351 3058

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026